Sponsored Content

Rioja Nature Pharma Expands Production Capacity With the Launch of Its Third Softgel Manufacturing Line

Rioja Nature Pharma has announced the commissioning of its third softgel production line, strengthening its position in the nutraceutical sector at a time when this format continues to grow globally in demand and strategic relevance.

With this new line, the company significantly increases its manufacturing capacity and enhances its ability to support brands requiring high-volume production, agility, and robust technical support.

This installation is part of a broader expansion plan that includes the development of new production areas equipped with state-of-the-art technology, aimed at improving efficiency, precision, and automation across processes.

According to Rioja Nature Pharma, this milestone will allow the company to manage larger nutraceutical projects with shorter lead times, while maintaining the high standards of quality, traceability, and certification that define its operations.

With this investment, Rioja Nature Pharma reinforces its commitment to innovation and its strategy for sustainable growth in the international contract manufacturing landscape.

Read More